In this interview, we sat down with Fadi Roumieh to talk about his journey into medicinal cannabis, how clinician attitudes have shifted over the years, the myths that still surround the industry, and where he sees cannabinoid medicine heading next.

As Australia’s medicinal cannabis sector rapidly expands, regulatory oversight from the TGA is becoming increasingly strict.

Non-compliance carries risks far beyond financial penalties, it can cost businesses their reputation, operational capabilities, and patient trust.

Discover key insights on why robust compliance frameworks are essential for sustainable growth.